News
MASI
168.31
+0.48%
0.80
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
NASDAQ · 1d ago
Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA
NASDAQ · 1d ago
Integer Holdings Gains 34.4% in One Year: What's Driving the Stock?
NASDAQ · 1d ago
Merit Medical Stock Rises Following FDA Nod for WRAPSODY Device
NASDAQ · 2d ago
Weekly Report: what happened at MASI last week (1216-1220)?
Weekly Report · 3d ago
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
NASDAQ · 5d ago
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
NASDAQ · 5d ago
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
NASDAQ · 6d ago
4 Healthcare Technology Innovators to Invest in Before the New Year
NASDAQ · 6d ago
ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSM
NASDAQ · 6d ago
Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50%
Simply Wall St · 6d ago
DaVita Stock Gains 40.1% Year to Date: What's Behind the Rally?
NASDAQ · 6d ago
Masimo Is Maintained at Overweight by Piper Sandler
Dow Jones · 12/18 17:37
Piper Sandler Maintains Overweight on Masimo, Raises Price Target to $210
Benzinga · 12/18 17:27
DXCM Stock Gains on the Launch of Proprietary Generative AI Platform
NASDAQ · 12/18 15:34
Masimo price target raised to $210 from $180 at Piper Sandler
TipRanks · 12/18 13:51
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
NASDAQ · 12/18 12:36
Reasons to Add McKesson Stock to Your Portfolio Right Now
NASDAQ · 12/18 12:35
MASIMO CORP <MASI.O>: PIPER SANDLER RAISES TARGET PRICE TO $210 FROM $180
Reuters · 12/18 08:40
U.S. RESEARCH ROUNDUP-First Solar, GE Vernova, Williams-Sonoma
Reuters · 12/18 06:54
More
Webull provides a variety of real-time MASI stock news. You can receive the latest news about Masimo Corp through multiple platforms. This information may help you make smarter investment decisions.
About MASI
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.